Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Brantley

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
The Journal of Clinical Investigation|June 19, 2002
Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastasesRebecca S Muraoka, Nancy Dumont, Christoph A Ritter, et al.
JCI Insight|August 8, 2020
Selective inhibition of mTORC1 in tumor vessels increases antitumor immunityShan Wang, Ariel Raybuck, Eileen Shiuan, et al.
The Journal of Clinical Investigation|September 25, 2014
Efferocytosis produces a prometastatic landscape during postpartum mammary gland involutionJamie C Stanford, Christian Young, Donna Hicks, et al.
Plos One|October 26, 2016
LIM-Only Protein 4 (LMO4) and LIM Domain Binding Protein 1 (LDB1) Promote Growth and Metastasis of Human Head and Neck Cancer (LMO4 and LDB1 in Head and Neck Cancer)Elizabeth A Simonik, Ying Cai, Katherine N Kimmelshue, et al.
Molecular Cancer Therapeutics|October 9, 2020
Repurposing of a Thromboxane Receptor Inhibitor Based on a Novel Role in Metastasis Identified by Phenome-Wide Association StudyThomas A Werfel, Donna J Hicks, Bushra Rahman, et al.
The Journal of Clinical Investigation|April 10, 2014
Genetic and pharmacologic inhibition of EPHA2 promotes apoptosis in NSCLCKatherine R Amato, Shan Wang, Andrew K Hastings, et al.
Cancer Research Communications|February 28, 2025
Induction of Triple-Negative Breast Cancer Cell Death and Chemosensitivity Using mTORC2-Directed RNAi NanomedicineShrusti S Patel, Rebecca S Cook, Justin H Lo, et al.
Cancer Research|January 24, 2018
Selective mTORC2 Inhibitor Therapeutically Blocks Breast Cancer Cell Growth and SurvivalThomas A Werfel, Shan Wang, Meredith A Jackson, et al.
Molecular & Cellular Proteomics : MCP|May 9, 2015
Activating PIK3CA Mutations Induce an Epidermal Growth Factor Receptor (EGFR)/Extracellular Signal-regulated Kinase (ERK) Paracrine Signaling Axis in Basal-like Breast CancerChristian D Young, Lisa J Zimmerman, Daisuke Hoshino, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
The Journal of Clinical Investigation|June 19, 2002
Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastasesRebecca S Muraoka, Nancy Dumont, Christoph A Ritter, et al.
JCI Insight|August 8, 2020
Selective inhibition of mTORC1 in tumor vessels increases antitumor immunityShan Wang, Ariel Raybuck, Eileen Shiuan, et al.
The Journal of Clinical Investigation|September 25, 2014
Efferocytosis produces a prometastatic landscape during postpartum mammary gland involutionJamie C Stanford, Christian Young, Donna Hicks, et al.
Plos One|October 26, 2016
LIM-Only Protein 4 (LMO4) and LIM Domain Binding Protein 1 (LDB1) Promote Growth and Metastasis of Human Head and Neck Cancer (LMO4 and LDB1 in Head and Neck Cancer)Elizabeth A Simonik, Ying Cai, Katherine N Kimmelshue, et al.
Molecular Cancer Therapeutics|October 9, 2020
Repurposing of a Thromboxane Receptor Inhibitor Based on a Novel Role in Metastasis Identified by Phenome-Wide Association StudyThomas A Werfel, Donna J Hicks, Bushra Rahman, et al.
The Journal of Clinical Investigation|April 10, 2014
Genetic and pharmacologic inhibition of EPHA2 promotes apoptosis in NSCLCKatherine R Amato, Shan Wang, Andrew K Hastings, et al.
Cancer Research Communications|February 28, 2025
Induction of Triple-Negative Breast Cancer Cell Death and Chemosensitivity Using mTORC2-Directed RNAi NanomedicineShrusti S Patel, Rebecca S Cook, Justin H Lo, et al.
Cancer Research|January 24, 2018
Selective mTORC2 Inhibitor Therapeutically Blocks Breast Cancer Cell Growth and SurvivalThomas A Werfel, Shan Wang, Meredith A Jackson, et al.
Molecular & Cellular Proteomics : MCP|May 9, 2015
Activating PIK3CA Mutations Induce an Epidermal Growth Factor Receptor (EGFR)/Extracellular Signal-regulated Kinase (ERK) Paracrine Signaling Axis in Basal-like Breast CancerChristian D Young, Lisa J Zimmerman, Daisuke Hoshino, et al.
Pageof 7